U.S., Dec. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07275749) titled 'Acetyl-leucine in Post-stroke Ataxia' on Nov. 24.
Brief Summary: Along with the current clinical trial, the efficacy and safety of 4 gram of acetyl-leucine daily for three months in patients with post-stroke ataxia following posterior-circulation ischaemic stroke assessed through BBS, SARA, and mRS, and possible adverse effects.
Study Start Date: Dec. 01
Study Type: INTERVENTIONAL
Condition:
Ischemic Stroke
Intervention:
DRUG: Acetyl-Leucine
The acetyl-leucine arm will receive (a 4 gram of acetyl-leucine daily for three months and an open-label loading 300 mg aspirin and 300 mg clopidogrel during the first 24 hours of stroke,...